{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:05:44Z","timestamp":1775307944360,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While vaccines traditionally have been designed and used for protection against infection or disease caused by one specific pathogen, there are known off-target effects from vaccines that can impact infection from unrelated pathogens. The best-known non-specific effects from an unrelated or heterologous vaccine are from the use of the Bacillus Calmette-Gu\u00e9rin (BCG) vaccine, mediated partly through trained immunity. Other vaccines have similar heterologous effects. This review covers molecular mechanisms behind the heterologous effects, and the potential use of heterologous vaccination in the current COVID-19 pandemic. We then discuss novel pandemic response strategies based on rapidly deployed, widespread heterologous vaccination to boost population-level immunity for initial, partial protection against infection and\/or clinical disease, while specific vaccines are developed.<\/jats:p>","DOI":"10.1186\/s10020-021-00317-z","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T08:04:21Z","timestamp":1622448261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Heterologous vaccine interventions: boosting immunity against future pandemics"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-6881","authenticated-orcid":false,"given":"Daniela","family":"Mar\u00edn-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas F.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Hupert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"317_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.08.011","author":"P Aaby","year":"2019","unstructured":"Aaby P, Benn CS. Developing the concept of beneficial non-specific effect of live vaccines with epidemiological studies. Clin Microbiol Infection. 2019. https:\/\/doi.org\/10.1016\/j.cmi.2019.08.011.","journal-title":"Clin Microbiol Infection."},{"issue":"1","key":"317_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0163-4453(84)93192-X","volume":"8","author":"P Aaby","year":"1984","unstructured":"Aaby P, Bukh J, Lisse IM, Smits AJ. Measles vaccination and reduction in child mortality: a community study from guinea-bissau. J Infect. 1984;8(1):13\u201321. https:\/\/doi.org\/10.1016\/S0163-4453(84)93192-X.","journal-title":"J Infect"},{"issue":"7785","key":"317_CR3","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/bmj.c6495","volume":"341","author":"P Aaby","year":"2010","unstructured":"Aaby P, Martins CL, Garly ML, Bal\u00e9 C, Andersen A, Rodrigues A, Ravn H, Lisse IM, Benn CS, Whittle HC. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ (online). 2010;341(7785):1262. https:\/\/doi.org\/10.1136\/bmj.c6495.","journal-title":"BMJ (online)"},{"issue":"23","key":"317_CR4","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1016\/j.vaccine.2004.02.009","volume":"22","author":"P Aaby","year":"2004","unstructured":"Aaby P, Rodrigues A, Biai S, Martins C, Veirum JE, Benn CS, Jensen H. Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine. 2004;22(23):3014\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.009.","journal-title":"Vaccine"},{"issue":"2","key":"317_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Stensballe L, et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011;204(2):245\u201352. https:\/\/doi.org\/10.1093\/infdis\/jir240.","journal-title":"J Infect Dis"},{"issue":"7003","key":"317_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/bmj.311.7003.481","volume":"311","author":"P Aaby","year":"1995","unstructured":"Aaby P, Samb B, Simondon F, Seck AMC, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ. 1995;311(7003):481. https:\/\/doi.org\/10.1136\/bmj.311.7003.481.","journal-title":"BMJ"},{"key":"317_CR7","doi-asserted-by":"publisher","unstructured":"van Aalst S, Irene LS, Ruurd van der Z, Willem van E, Broere B. Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant. Edited by Irun R. Cohen. PLOS ONE 12 (5): e0177365. doi: https:\/\/doi.org\/10.1371\/journal.pone.0177365.","DOI":"10.1371\/journal.pone.0177365"},{"issue":"3","key":"317_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/vaccines8030535","volume":"8","author":"M Amato","year":"2020","unstructured":"Amato M, Werba JP, Frigerio B, Coggi D, Sansaro D, Ravani A, Ferrante P, Veglia F, Tremoli E, Baldassarre D. Relationship between influenza vaccination coverage rate and covid-19 outbreak: an Italian ecological study. Vaccines. 2020;8(3):535. https:\/\/doi.org\/10.3390\/vaccines8030535.","journal-title":"Vaccines"},{"key":"317_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00013","author":"A Andreas","year":"2018","unstructured":"Andreas A, Fisker AB, Rodrigues A, Martins C, Ravn H, Lund N, Biering-S\u00f8rensen S, Benn CS, Aaby P. National immunization campaigns with oral polio vaccine reduce all-cause mortality: a natural experiment within seven randomized trials. Front Public Health. 2018. https:\/\/doi.org\/10.3389\/fpubh.2018.00013.","journal-title":"Front Public Health."},{"issue":"5","key":"317_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/cid\/cix442","volume":"65","author":"BH Bardenheier","year":"2017","unstructured":"Bardenheier BH, McNeil MM, Patricia Wodi A, McNicholl JM, DeStefano F. Risk of nontargeted infectious disease hospitalizations among us children following inactivated and live vaccines, 2005\u20132014. Clin Infect Dis. 2017;65(5):729\u201337. https:\/\/doi.org\/10.1093\/cid\/cix442.","journal-title":"Clin Infect Dis"},{"issue":"5601","key":"317_CR11","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","volume":"298","author":"NL Bernasconi","year":"2002","unstructured":"Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298(5601):2199\u2013202. https:\/\/doi.org\/10.1126\/science.1076071.","journal-title":"Science"},{"issue":"3","key":"317_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","volume":"31","author":"S Biering-S\u00f8rensen","year":"2012","unstructured":"Biering-S\u00f8rensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small randomized trial among low-birth-weight children receiving bacillus calmette-gu\u00e9erin vaccination at first health center contact. Pediatric Infect Dis J. 2012;31(3):306\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e3182458289.","journal-title":"Pediatric Infect Dis J"},{"issue":"3","key":"317_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1189\/jlb.5RI0315-096R","volume":"98","author":"BA Blok","year":"2015","unstructured":"Blok BA, Arts RJW, van Crevel R, Benn CS, Netea MG. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. J Leukoc Biol. 2015;98(3):347\u201356. https:\/\/doi.org\/10.1189\/jlb.5RI0315-096R.","journal-title":"J Leukoc Biol"},{"key":"317_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12982-014-0022-3","author":"C Bottomley","year":"2015","unstructured":"Bottomley C, Bojang A, Smith PG, Darboe O, Antonio M, Foster-Nyarko E, Kampmann B, Greenwood B, D\u2019Alessandro U, Roca A. The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study. Emerg Themes Epidemiol. 2015. https:\/\/doi.org\/10.1186\/s12982-014-0022-3.","journal-title":"Emerg Themes Epidemiol"},{"key":"317_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.092","author":"B Brook","year":"2021","unstructured":"Brook B, Schaltz-Buchholzer F, Ben-Othman R, Kollmann T, Amenyogbe N. A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine. Vaccine. 2021. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.092.","journal-title":"Vaccine"},{"issue":"11","key":"317_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/cid\/civ144","volume":"60","author":"MJ Castro","year":"2015","unstructured":"Castro MJ, De J-S, Martin\u00f3n-Torres F. Nonspecific (Heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. Clin Infect Dis. 2015;60(11):1611\u20139. https:\/\/doi.org\/10.1093\/cid\/civ144.","journal-title":"Clin Infect Dis"},{"key":"317_CR17","unstructured":"CDC. ACIP Altered Immunocompetence Guidelines for Immunizations|CDC.\u201d 2021. https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/immunocompetence.html."},{"issue":"6496","key":"317_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1126\/science.abc4262","volume":"368","author":"K Chumakov","year":"2020","unstructured":"Chumakov K, Christine SB, Aaby P, Kottilil S, Robert G. Can existing live vaccines prevent COVID-19? Science. 2020;368(6496):1187\u20138. https:\/\/doi.org\/10.1126\/science.abc4262.","journal-title":"Science"},{"issue":"2","key":"317_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic B, Charlotte LJB, Groh L, BlokBA Chan J, van der Velden WJFM, Bremmers MEJ, et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe. 2020;28(2):322-334.e5. https:\/\/doi.org\/10.1016\/j.chom.2020.05.014.","journal-title":"Cell Host Microbe"},{"key":"317_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.14.20212498","author":"PA Debisarun","year":"2020","unstructured":"Debisarun PA, Patrick S, Jorge D-A, Simone JCFM, Moorlag ET, Katharina LG, Philipp NO, et al. The effect of influenza vaccination on trained immunity: impact on COVID-19. MedRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.10.14.20212498.","journal-title":"MedRxiv"},{"key":"317_CR21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008410117","author":"LE Escobar","year":"2020","unstructured":"Escobar LE, Alvaro M-C, Barillas-Mury Carolina. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci. 2020. https:\/\/doi.org\/10.1073\/pnas.2008410117.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"317_CR22","doi-asserted-by":"publisher","first-page":"e1831","DOI":"10.1371\/journal.pone.0001831","volume":"3","author":"S Frankild","year":"2008","unstructured":"Frankild S, de Boer RJ, Lund O, Nielsen M, Kesmir C. Amino acid similarity accounts for T cell cross-reactivity and for \u2018Holes\u2019 in the T cell repertoire Edited by Linqi Zhang. Plos ONE. 2008;3(3):e1831. https:\/\/doi.org\/10.1371\/journal.pone.0001831.","journal-title":"Plos ONE"},{"issue":"1","key":"317_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/trstmh\/tru197","volume":"109","author":"B Freyne","year":"2015","unstructured":"Freyne B, Marchant A, Curtis N. BCG-associated heterologous immunity, a historical perspective: intervention studies in animal models of infectious diseases. Trans R Soc Trop Med Hyg. 2015;109(1):52\u201361. https:\/\/doi.org\/10.1093\/trstmh\/tru197.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"21\u201322","key":"317_CR24","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","volume":"21","author":"ML Garly","year":"2003","unstructured":"Garly ML, Martins CL, Bal\u00e9 C, Bald\u00e9 MA, Hedegaard KL, Gustafson P, Lisse IM, Whittle HC, Aaby P. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG? Vaccine. 2003;21(21\u201322):2782\u201390. https:\/\/doi.org\/10.1016\/S0264-410X(03)00181-6.","journal-title":"Vaccine"},{"key":"317_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.051","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Tsilika M, Moorlag S, Renieris G, Papadopoulos A, Netea MG, Correspondence NA, et al. Activate: randomized clinical trial of BCG vaccination against infection in the elderly. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.08.051.","journal-title":"Cell"},{"issue":"6","key":"317_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri.2016.43","volume":"16","author":"HS Goodridge","year":"2016","unstructured":"Goodridge HS, Sohail Ahmed S, Curtis N, Kollmann TR, Levy O, Netea MG, Pollard AJ, Van Crevel R, Wilson CB. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol. 2016;16(6):392\u2013400. https:\/\/doi.org\/10.1038\/nri.2016.43.","journal-title":"Nat Rev Immunol"},{"key":"317_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.015","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Daniela W, Sydney IR, Jose M, Jennifer MD, Carolyn RM, Stephen AR, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015.","journal-title":"Cell"},{"key":"317_CR28","doi-asserted-by":"publisher","first-page":"104187","DOI":"10.1016\/j.cellimm.2020.104187","volume":"356","author":"PK Gupta","year":"2020","unstructured":"Gupta PK. New disease old vaccine: is recombinant BCG vaccine an answer for COVID-19? Cell Immunol. 2020;356:104187. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104187.","journal-title":"Cell Immunol"},{"key":"317_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5170","author":"JPT Higgins","year":"2016","unstructured":"Higgins JPT, Soares-Weiser K, L\u00f3pez-L\u00f3pez JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JAC, Reingold AL. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ (online). 2016. https:\/\/doi.org\/10.1136\/bmj.i5170.","journal-title":"BMJ (online)"},{"key":"317_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100758","author":"N Hupert","year":"2021","unstructured":"Hupert N, Mar\u00edn-Hern\u00e1ndez D, Nixon DF. Can existing unrelated vaccines boost a COVID-19 vaccine prime? EClinicalMedicine. 2021. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100758.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"317_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LAB, Jacobs C, Van Loenhout J, et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J Innate Immun. 2014;6(2):152\u20138. https:\/\/doi.org\/10.1159\/000355628.","journal-title":"J Innate Immun"},{"issue":"12","key":"317_CR32","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","volume":"212","author":"J Leentjens","year":"2015","unstructured":"Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, Rimmelzwaan GF, Pickkers P, Netea MG. BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study. J Infect Dis. 2015;212(12):1930\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiv332.","journal-title":"J Infect Dis"},{"key":"317_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26120","author":"D Mar\u00edn-Hern\u00e1ndez","year":"2020","unstructured":"Mar\u00edn-Hern\u00e1ndez D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.26120.","journal-title":"J Med Virol"},{"issue":"5","key":"317_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1439-0450.2004.00763.x","volume":"51","author":"A Mayr","year":"2004","unstructured":"Mayr A. Taking advantage of the positive side-effects of smallpox vaccination. J Vetr Med Series B Infect Dis Vetr Public Health. 2004;51(5):199\u2013201. https:\/\/doi.org\/10.1111\/j.1439-0450.2004.00763.x.","journal-title":"J Vetr Med Series B Infect Dis Vetr Public Health"},{"issue":"1\u20132","key":"317_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis I, Ruppova K, Wang B, Chen LS, Grzybek M, Grinenko T, Eugster A, et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell. 2018;172(1\u20132):147-161.e12. https:\/\/doi.org\/10.1016\/j.cell.2017.11.034.","journal-title":"Cell"},{"issue":"12","key":"317_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"SJCFM Moorlag","year":"2019","unstructured":"Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25(12):1473\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.020.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"317_CR37","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.celrep.2020.108387","volume":"33","author":"SJCFM Moorlag","year":"2020","unstructured":"Moorlag SJCFM, Rodriguez-Rosales YA, Gillard J, Fanucchi S, Theunissen K, Novakovic B, de Bont CM, et al. BCG vaccination induces long-term functional reprogramming of human neutrophils. Cell Rep. 2020;33(7):108387. https:\/\/doi.org\/10.1016\/j.celrep.2020.108387.","journal-title":"Cell Rep"},{"key":"317_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","author":"MG Netea","year":"2020","unstructured":"Netea MG, Jorge D-A, Luis BB, Triantafyllos C, Maziar D, Elaine F, Leo ABJ, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-020-0285-6.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"317_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea MG, Quintin J, Van Der Meer JWM. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011;9(5):355\u201361. https:\/\/doi.org\/10.1016\/j.chom.2011.04.006.","journal-title":"Cell Host Microbe"},{"key":"317_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.14.095414","author":"KW Ng","year":"2020","unstructured":"Ng KW, Nikhil F, Georgina HC, Annachiara R, Ruth H, Saira H, Rachel U, et al. Pre-Existing and de novo humoral immunity to SARS-CoV-2 in humans. BioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.14.095414.","journal-title":"BioRxiv."},{"key":"317_CR41","unstructured":"NIH U.S.National Library of Medicine.2021.\u201cClinicalTrials.Gov\u201d.ClinicalTrials.Gov.2021.https:clinicaltrials.gov, ct2, resultsterm=BCGcond=COVIDdraw=3., 2021NIH U.S. National Library of Medicine. 2021. \u201cClinicalTrials.Gov.\u201d ClinicalTrials.Gov. 2021. https:\/\/clinicaltrials.gov\/ct2\/results?term=BCG&cond=COVID&draw=3."},{"issue":"1","key":"317_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3143\/geriatrics.42.34","volume":"42","author":"T Ohrui","year":"2005","unstructured":"Ohrui T, Nakayama K, Fukushima T, Chiba H, Sasaki H. Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations. Jpn J Geriatr. 2005;42(1):34\u20136. https:\/\/doi.org\/10.3143\/geriatrics.42.34.","journal-title":"Jpn J Geriatr"},{"issue":"1","key":"317_CR43","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/s41598-021-83641-y","volume":"11","author":"C Pawlowski","year":"2021","unstructured":"Pawlowski C, Puranik A, HariBandi AJ, Venkatakrishnan VA, Kennedy R, O\u2019Horo JC, et al. Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations. Sci Rep. 2021;11(1):4741. https:\/\/doi.org\/10.1038\/s41598-021-83641-y.","journal-title":"Sci Rep"},{"key":"317_CR44","doi-asserted-by":"publisher","first-page":"101876","DOI":"10.1016\/j.tube.2019.101876","volume":"119","author":"SA Prabowo","year":"2019","unstructured":"Prabowo SA, Smith SG, Seifert K, Fletcher HA. Impact of individual-level factors on ex vivo mycobacterial growth inhibition: associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans. Tuberculosis. 2019;119:101876. https:\/\/doi.org\/10.1016\/j.tube.2019.101876.","journal-title":"Tuberculosis"},{"key":"317_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx130","author":"A Rieckmann","year":"2017","unstructured":"Rieckmann A, Marie V, Mette LJ, Henrik R, Zacarias JS, Signe S, Jennifer LB, et al. The effect of smallpox and bacillus calmette-gu\u00e9rin vaccination on the risk of human immunodeficiency virus-1 infection in Guinea-Bissau and Denmark. Open Forum Infect Dis. 2017. https:\/\/doi.org\/10.1093\/ofid\/ofx130.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"317_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/ije\/dyw120","volume":"46","author":"A Rieckmann","year":"2017","unstructured":"Rieckmann A, Villumsen M, S\u00f8rup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a danish case-cohort study 1971\u20132010. Int J Epidemiol. 2017;46(2):695\u2013705. https:\/\/doi.org\/10.1093\/ije\/dyw120.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"317_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/ije\/dyh392","volume":"34","author":"A Roth","year":"2005","unstructured":"Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, Jensen H, Sodemann M, Rodriques A, Aaby P. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol. 2005;34(3):540\u20137. https:\/\/doi.org\/10.1093\/ije\/dyh392.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"317_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s42003-020-01288-3","volume":"3","author":"V Rozot","year":"2020","unstructured":"Rozot V, Nemes E, Geldenhuys H, Musvosvi M, Toefy A, Rantangee F, Makhethe L, et al. Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines. Commun Biol. 2020;3(1):11. https:\/\/doi.org\/10.1038\/s42003-020-01288-3.","journal-title":"Commun Biol"},{"key":"317_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02936","author":"S S\u00e1nchez-Ram\u00f3n","year":"2018","unstructured":"S\u00e1nchez-Ram\u00f3n S, Conejero L, Netea MG, Sancho D, Palomares \u00d3, Subiza JL. Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations. Front Immunol NLM (medline). 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.02936.","journal-title":"Front Immunol NLM (medline)"},{"issue":"47","key":"317_CR50","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1016\/j.vaccine.2011.09.015","volume":"29","author":"E Sepp\u00e4l\u00e4","year":"2011","unstructured":"Sepp\u00e4l\u00e4 E, Viskari H, Hoppu S, Honkanen H, Huhtala H, Simell O, Ilonen J, Knip M, Hy\u00f6ty H. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media. Vaccine. 2011;29(47):8615\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.015.","journal-title":"Vaccine"},{"issue":"8","key":"317_CR51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.2014.470","volume":"311","author":"S S\u00f8rup","year":"2014","unstructured":"S\u00f8rup S, Benn CS, Poulsen A, Krause TG, Aaby P, Ravn H. Live Vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA. 2014;311(8):826\u201335. https:\/\/doi.org\/10.1001\/jama.2014.470.","journal-title":"JAMA"},{"issue":"2","key":"317_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/cid\/ciy433","volume":"68","author":"S S\u00f8rup","year":"2019","unstructured":"S\u00f8rup S, Jensen AKG, Aaby P, Benn CS. Revaccination with measles-mumps-rubella vaccine and infectious disease morbidity: a Danish register-based cohort study. Clin Infect Dis. 2019;68(2):282\u201390. https:\/\/doi.org\/10.1093\/cid\/ciy433.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"317_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/ije\/dyr063","volume":"40","author":"S S\u00f8rup","year":"2011","unstructured":"S\u00f8rup S, Villumsen M, Ravn H, Benn CS, S\u00f8rensen TIA, Aaby P, Jess T, Roth A. Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. Int J Epidemiol. 2011;40(4):955\u201363. https:\/\/doi.org\/10.1093\/ije\/dyr063.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"317_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2012.10.021","volume":"38","author":"LF Su","year":"2013","unstructured":"Su LF, Kidd BA, Han A, Kotzin JJ, Davis MM. Virus-Specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity. 2013;38(2):373\u201383. https:\/\/doi.org\/10.1016\/j.immuni.2012.10.021.","journal-title":"Immunity"},{"issue":"11","key":"317_CR55","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.4049\/jimmunol.1900674","volume":"203","author":"S Suliman","year":"2019","unstructured":"Suliman S, Murphy M, Musvosvi M, Gela A, Meermeier EW, Geldenhuys H, Hopley C, et al. MR1-independent activation of human mucosal-associated invariant T cells by mycobacteria. J Immunol. 2019;203(11):2917\u201327. https:\/\/doi.org\/10.4049\/jimmunol.1900674.","journal-title":"J Immunol"},{"issue":"3","key":"317_CR56","first-page":"185","volume":"43","author":"EAD Wardhana","year":"2011","unstructured":"Wardhana EAD, Sultana A, Mandang VV, Jim E. The efficacy of bacillus calmette-guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly. Acta Medica Indonesiana. 2011;43(3):185\u201390.","journal-title":"Acta Medica Indonesiana"},{"issue":"May","key":"317_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2172-11-23","volume":"11","author":"RS Weinstein","year":"2010","unstructured":"Weinstein RS, Weinstein MM, Alibek K, Bukrinsky MI, Brichacek B. Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with vaccinia virus. BMC Immunol. 2010;11(May):23. https:\/\/doi.org\/10.1186\/1471-2172-11-23.","journal-title":"BMC Immunol"},{"key":"317_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00028","author":"P Welaga","year":"2018","unstructured":"Welaga P, Abraham H, Cornelius D, Peter A, Fred B, Daniel A, Abraham O. Measles vaccination supports millennium development goal 4: increasing coverage and increasing child survival in Northern Ghana, 1996\u20132012. Front Public Health. 2018. https:\/\/doi.org\/10.3389\/fpubh.2018.00028.","journal-title":"Front Public Health"},{"issue":"2","key":"317_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vaccine.2019.10.005","volume":"38","author":"GG Wolff","year":"2020","unstructured":"Wolff GG. Influenza vaccination and respiratory virus interference among department of defense personnel during the 2017\u20132018 influenza season. Vaccine. 2020;38(2):350\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.005.","journal-title":"Vaccine"},{"key":"317_CR60","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.24.20129817","author":"C Zanettini","year":"2020","unstructured":"Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L. Influenza vaccination and COVID19 mortality in the USA. MedRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.06.24.20129817.","journal-title":"MedRxiv"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00317-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00317-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T08:11:43Z","timestamp":1622448703000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00317-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00317-z","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"25 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}